LeMaitre Vascular (LMAT) will increase its quarterly dividend by 15.8 percent to $0.11 per share in 2021. This follows a dividend hike of 11.8 percent to $0.095 per share in the first quarter of 2020 and also marks 9 consecutive years of dividend increases by the medical devices maker.

The increased dividend will be paid March 25, 2021 to shareholders of record on March 9, 2021. A new annualized dividend rate of 44 cents per share yields 0.9% at a stock price of $50.49 for LeMaitre Vascular.

LeMaitre Vascular, Inc. is a global provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons. The company's portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and include the HYDRO Expandable LeMaitre Valvulotome, the XenoSure biologic patch, the Pruitt F3 Carotid Shunt and VascuTape Radiopaque Tape. The company's products are sold worldwide, primarily in the United States, Europe and, to a lesser extent, Asia and the Pacific Rim.